Letter to HHS and FDA: Forced Switch Share page: We understand that FDA is considering a switch of a second generation antihistamine, from prescription to OTC status, over the objections of the company. CHPA opposes a policy to force switch over the objections of the drug sponsor. Download Document Issues: OTC Medicines Rx-to-OTC Switch Related Posts Articles Polibrief: Post-Consumer Recycled Content Jul 9, 2024 Press Releases and Statements CHPA Statement on U.S. Supreme Court Overturning the Chevron Standard Jun 28, 2024 Press Releases and Statements CHPA Welcomes New Board Members at June Meeting Jun 14, 2024